Filing Details
- Accession Number:
- 0001062993-22-002733
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-04 19:33:09
- Reporting Period:
- 2022-02-02
- Accepted Time:
- 2022-02-04 19:33:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1822691 | Greenlight Biosciences Holdings Pbc | GRNA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1083218 | Ganesh Kishore | C/O Greenlight Biosciences Holdings, Pbc 200 Boston Avenue, Suite 3100 Medford MA 02155 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-02-02 | 5,743,575 | $0.00 | 5,743,575 | No | 4 | A | Indirect | by MLS Capital Fund II, L.P. |
Common Stock | Acquisiton | 2022-02-02 | 75,000 | $10.00 | 5,818,575 | No | 4 | P | Indirect | by MLS Capital Fund II, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Indirect | by MLS Capital Fund II, L.P. |
No | 4 | P | Indirect | by MLS Capital Fund II, L.P. |
Footnotes
- Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company.
- Mr. Kishore, a director of the Issuer, is the Manager of MLS Capital fund II, L.P. and has the power to vote, or to direct the voting of, the shares held by MLS Capital fund II, L.P. By virtue of the foregoing, Mr. Kishore may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the shares held by MLS Capital fund II, L.P. Mr. Kishore disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.
- Amount consists of 75,000 shares of common stock issued pursuant to a subscription agreement entered into between the Issuer and MLS Capital fund II, L.P.